Profil
Andrew Krishna Ekaputra is currently Senior Principal at EDB Investments Pte Ltd since 2023 and a Member of Tissue Engineering & Generative Medicine International Society.
Formerly, Dr. Ekaputra was Technical Director at Cordlife Group Ltd. Dr. Ekaputra completed undergraduate and doctorate degrees at the National University of Singapore, conferred in 2003 and 2010 respectively.
Postes actifs de Andrew Ekaputra
| Sociétés | Poste | Début |
|---|---|---|
Tissue Engineering & Generative Medicine International Societ | Corporate Officer/Principal | - |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDBI invests in companies located in Asia primarily in Singapore. The firm focuses on bio-based economy, green economy, next-generation hardware, mobility, health & wellness and digital economy sectors. It provides equity financing for later stage capital requirements. | Private Equity Investor | 01/07/2023 |
Anciens postes connus de Andrew Ekaputra
| Sociétés | Poste | Fin |
|---|---|---|
| CORDLIFE GROUP LIMITED | Directeur Technique/Scientifique/R&D | - |
Formation de Andrew Ekaputra
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDBI invests in companies located in Asia primarily in Singapore. The firm focuses on bio-based economy, green economy, next-generation hardware, mobility, health & wellness and digital economy sectors. It provides equity financing for later stage capital requirements. | Finance |
Cordlife Group Ltd.
Cordlife Group Ltd. Medical/Nursing ServicesHealth Services Provides cord blood banking services | Health Services |
Tissue Engineering & Generative Medicine International Societ |
















